---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-316929"
form_type: "8-K"
ticker: "AURA"
cik: "0001501796"
company_name: "Aura Biosciences, Inc."
filed_at: "2021-11-02T23:59:59+00:00"
generated_at: "2026-06-28T15:04:10.956462+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Aura Biosciences amends charter and bylaws upon IPO; authorizes 150M common shares

## Summary
- Authorized 150 million shares of common stock and 10 million shares of undesignated preferred stock.
- Eliminated all references to prior series of preferred stock from charter.
- Amended bylaws effective Oct 28, 2021: removed stockholder written consent and special meeting rights.
- Established procedures for stockholder proposals and director nominations in bylaws.
- All changes were previously disclosed in IPO registration statement S-1.

## SEC filing metadata
- accession: 0001193125-21-316929
- form_type: 8-K
- ticker: AURA
- cik: 0001501796
- company_name: Aura Biosciences, Inc.
- filed_at: 2021-11-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501796/000119312521316929/0001193125-21-316929-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501796/000119312521316929/d211948d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-316929
- JSON: https://secwatch.observer/filing/0001193125-21-316929.json
- Plain text: https://secwatch.observer/filing/0001193125-21-316929.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.